Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Revolutionary inverter technology leads the clean energy charge (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp > Howhee- Tinyi Trading Co???
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(27)
•••
Comment by Ticklel1ston Oct 03, 2021 11:52am
116 Views
Post# 33958705

RE:RE:Howhee- Tinyi Trading Co???

RE:RE:Howhee- Tinyi Trading Co???Hello Not So Crazydan.

That is the company I was referring to as very suspect as an internet search of the address showed an emty park. And nothing could be found on th company except a new website was coming...which never happened.

Yup..lots of big  top 10 world phantom Pharma deals in the works  that when you try and search them turns up nothing on google. Right up a Vancouver Scam Exchanges alley when creating NRS promoting big deals I guess.

Howhee...you got a website for Tinyi....or a real company name to search that will need lead to an emty park otr a new website coming? Have your lap  dog post it for us.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities